Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 11 X users

Citations

dimensions_citation: 46 Dimensions

Readers on

mendeley: 61 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 18 X posts from 11 X users, with an upper bound of 39,404 followers.

News in the #GVAX field, a more complex combo: Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer https://t.co/wpCcWj4xvS #cancer #immunotherapy $ADRO

20 Dec 2018

Reply Repost Favourite

Spotlight: (Original article appears in Journal for Immunotherapy of Cancer https://t.co/CBqVALk4i9) @HopkinsKimmel @HopkinsMedicine #DC #PD1 #pancreatic #cancer https://t.co/aWVK2zjaDu

13 Dec 2018

Reply Repost Favourite

RT @sitcancer: #JITC Research: Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine mod…

07 Dec 2018

Reply Repost Favourite

#JITC Research: Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer https://t.co/Ar3vErKDQN https://t.co/C2oNN0VNby

06 Dec 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 14 additional X posts.